"It's not just about the lab or the science," says Dr. Lasse Dissing-Olesen, who recently completed his PhD in Dr. Brian MacVicar's lab. "The feeling of accomplishment comes from so many different things."
The Honourable Dr. K. Kellie Leitch, Minister of Labour and Minister of Status of Women, and David Sweet, Member of Parliament for Ancaster–Dundas–Flamborough–Westdale, on behalf of the Honourable Rona Ambrose, Minister of Health, today met with researchers and participants in the Canadian Longitudinal Study on Aging (CLSA), Canada’s largest ever study on aging. Minister Leitch and MP Sweet congratulated the research team on reaching their ambitious recruitment goal and thanked the participants from across the country for agreeing to take part in the important study.
On the path from the eye to the brain, visual information travels between neurons via glutamate. Glutamate levels are crucial to cell communication: too high and neurons die, too low and information cannot be properly understood. In either case, the wrong balance of glutamate in the neurons can contribute to neurological diseases including stroke, glaucoma, and Alzheimer's.
Effective help for depression and anxiety is now just a click away, thanks to a mobile-optimized website developed at the Mood Disorders Clinic at the Djavad Mowafaghian Centre for Brain Health. MoodFx, accessible by mobile device or computer, uses validated questionnaires to track patients’ mood, cognition and work performance.
The Canadian Association for Neuroscience, Djavad Mowafaghian Centre for Brain Health and Science World have teamed up to present latest neuroscience research to the public.
Researchers at the Djavad Mowafaghian Centre for Brain Health say a new epilepsy drug holds promise as a treatment for Alzheimer’s disease.
Acknowledging the influence of female physiology is essential to providing effective, individualized treatment.